NEW YORK, Sept. 28, 2017 /PRNewswire/ -- Envoy Capital Management, LLC ("Envoy"), an alternative asset manager, announced the recent funding of a unitranche facility to support the recapitalization of a pharmacy benefit management (PBM) company. The Company is privately owned by members of management and a syndicate of family offices.
The Company provides prescription drug management on behalf of corporations, municipalities and universities through an integrated, nationwide network of retail pharmacies. The Company focuses on developing strategies to offset rising pharmaceutical costs while balancing access and affordability for plan members. The Company also offers mail order and specialty drug pharmacy capabilities through wholly-owned subsidiaries.
Partner Neil Marks noted "Envoy was founded on the strategy of supporting family offices, entrepreneurs and independent sponsors, so we are pleased to further that mission as part of this transaction."
For further information please visit www.envoymanagement.com.
About Envoy Management
Envoy Management is a private investment firm based in New York which provides senior and subordinated debt and equity to middle market businesses to support independent sponsors, family offices, owner operators and private equity funds. Envoy's principals have made investments in a wide range of industries over several decades, including healthcare, business services, industrial and consumer products.
For more information, please contact:
Neil A. Marks
SOURCE Envoy Management